{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:33Z","timestamp":1792782873612,"version":"4.5.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Minufiya University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Obesity is a global health issue that is intricately linked to the development and progression of chronic liver disease (CLD). This bidirectional connection, coupled with the obesity paradox (OP), presents a management dilemma. The established influence of obesity on the development and progression of chronic liver disease (CLD) is surpassed by the liver\u2019s impact on the onset and advancement of obesity. Patients with CLD always experience increased energy expenditure, reduced appetite, and low protein synthesis, all of which might lead to weight loss. However, metabolic disturbances, hormonal imbalances, inflammatory signaling, immobility, drugs, and alterations in nutrient metabolism can contribute to the development and exacerbation of obesity. Despite the propagation of the OP concept, none of the guidelines has changed, recommending being overweight. Research bias and confounders might be the lifebuoy explanation. Additionally, overlooking the lethal morbidities of obesity for survival benefits full of suffering seems to be an illogical idea. Therefore, rather than endorsing an overweight status, emphasis should be placed on improving cardiorespiratory fitness and preventing sarcopenia to achieve better outcomes in patients with CLD. Accordingly, the complex interplay between obesity, CLD, and the concept of OP requires a sophisticated individualized management approach. Maximizing cardiorespiratory fitness and mitigating sarcopenia should be considered essential strategies for attaining the most favourable outcomes in patients with chronic liver disease (CLD).<\/jats:p>","DOI":"10.1007\/s10238-024-01493-y","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T13:02:19Z","timestamp":1728910939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Liver at crossroads: unraveling the links between obesity, chronic liver diseases, and the mysterious obesity paradox"],"prefix":"10.1007","volume":"24","author":[{"given":"Maha","family":"Elsabaawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"1493_CR1","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155217","volume":"133","author":"C Boutari","year":"2022","unstructured":"Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133: 155217.","journal-title":"Metabolism"},{"issue":"3","key":"1493_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, et al. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr. 2023;32(3):197\u2013213.","journal-title":"J Obes Metab Syndr"},{"issue":"2","key":"1493_CR3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679\u201389.","journal-title":"Hepatology"},{"issue":"4","key":"1493_CR4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ccc.2010.06.004","volume":"26","author":"DE Amundson","year":"2010","unstructured":"Amundson DE, Djurkovic S, Matwiyoff GN. The obesity paradox. Crit Care Clin. 2010;26(4):583\u201396.","journal-title":"Crit Care Clin"},{"issue":"10","key":"1493_CR5","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.3390\/jcm11102842","volume":"11","author":"J Faccioli","year":"2022","unstructured":"Faccioli J, Nardelli S, Gioia S, et al. Nutrition assessment and management in patients with cirrhosis and cognitive impairment: a comprehensive review of literature. J Clin Med. 2022;11(10):2842.","journal-title":"J Clin Med"},{"issue":"3","key":"1493_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s13679-022-00474-0","volume":"11","author":"SA Polyzos","year":"2022","unstructured":"Polyzos SA, Goulis DG, Giouleme O, Germanidis GS, Goulas A. Anti-obesity medications for the management of nonalcoholic fatty liver disease. Curr Obes Rep. 2022;11(3):166\u201379. https:\/\/doi.org\/10.1007\/s13679-022-00474-0.","journal-title":"Curr Obes Rep"},{"issue":"10","key":"1493_CR7","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/nu14102140","volume":"14","author":"Y Ding","year":"2022","unstructured":"Ding Y, Xu X, Tian T, Yu C, Ge X, Gao J, Lu J, Ge Z, Jiang T, Jiang Y, Ma H, Song C, Hu Z. Weight change across adulthood in relation to non-alcoholic fatty liver disease among non-obese individuals. Nutrients. 2022;14(10):2140. https:\/\/doi.org\/10.3390\/nu14102140.","journal-title":"Nutrients"},{"issue":"11","key":"1493_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/DMSO.S146339","volume":"25","author":"R Sarwar","year":"2018","unstructured":"Sarwar R, Pierce N, Koppe S. Obesity and nonalcoholic fatty liver disease: current perspectives. Diabetes Metab Syndr Obes. 2018;25(11):533\u201342. https:\/\/doi.org\/10.2147\/DMSO.S146339.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"1493_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/ncp.10458","volume":"35","author":"MA Fallahzadeh","year":"2020","unstructured":"Fallahzadeh MA, Rahimi RS. Hepatic encephalopathy and nutrition influences: a narrative review. Nutr Clin Pract. 2020;35(1):36\u201348. https:\/\/doi.org\/10.1002\/ncp.10458.","journal-title":"Nutr Clin Pract"},{"key":"1493_CR10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397.","journal-title":"Metabolism"},{"issue":"6","key":"1493_CR11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu DW, Yan HY, et al. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17(6):510\u20139.","journal-title":"Obes Rev"},{"issue":"4","key":"1493_CR12","volume":"16","author":"C Liu","year":"2021","unstructured":"Liu C, Shao M, Lu L, et al. Obesity, insulin resistance and their interaction on liver enzymes. PLoS ONE. 2021;16(4): e0249299.","journal-title":"PLoS ONE"},{"issue":"1","key":"1493_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.gendis.2014.07.007","volume":"1","author":"Y Chen","year":"2014","unstructured":"Chen Y, Varghese Z, Ruan XZ. The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis. Genes Dis. 2014;1(1):106\u201312. https:\/\/doi.org\/10.1016\/j.gendis.2014.07.007.","journal-title":"Genes Dis"},{"issue":"Suppl 1","key":"1493_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000178028","volume":"71","author":"AM Cali","year":"2009","unstructured":"Cali AM, Caprio S. Ectopic fat deposition and the metabolic syndrome in obese children and adolescents. Horm Res. 2009;71(Suppl 1):2\u20137. https:\/\/doi.org\/10.1159\/000178028.","journal-title":"Horm Res"},{"issue":"10","key":"1493_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.11124\/jbisrir-2015-2458","volume":"13","author":"P Secombe","year":"2015","unstructured":"Secombe P, Harley S, Chapman M, Aromataris E. Feeding the critically ill obese patient: a systematic review protocol. JBI Database Syst Rev Implement Rep. 2015;13(10):95\u2013109. https:\/\/doi.org\/10.11124\/jbisrir-2015-2458.","journal-title":"JBI Database Syst Rev Implement Rep"},{"issue":"5","key":"1493_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/MED.0000000000000432","volume":"25","author":"SE Mathews","year":"2018","unstructured":"Mathews SE, Kumar RB, Shukla AP. Nonalcoholic steatohepatitis, obesity, and cardiac dysfunction. Curr Opin Endocrinol Diabetes Obes. 2018;25(5):315\u201320. https:\/\/doi.org\/10.1097\/MED.0000000000000432.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"13","key":"1493_CR17","volume":"6","author":"Y Duan","year":"2022","unstructured":"Duan Y, Pan X, Luo J, et al. Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front Immunol. 2022;6(13): 880298.","journal-title":"Front Immunol"},{"key":"1493_CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-319-48382-5_8","volume":"960","author":"AB Engin","year":"2017","unstructured":"Engin AB. What is lipotoxicity? Adv Exp Med Biol. 2017;960:197\u2013220.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"1493_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/nu13020301","volume":"13","author":"R Rezzani","year":"2021","unstructured":"Rezzani R, Franco C. Liver, oxidative stress and metabolic syndromes. Nutrients. 2021;13(2):301. https:\/\/doi.org\/10.3390\/nu13020301.","journal-title":"Nutrients"},{"issue":"13","key":"1493_CR20","doi-asserted-by":"crossref","first-page":"1025706","DOI":"10.3389\/fendo.2022.1025706","volume":"20","author":"Z Cheng","year":"2022","unstructured":"Cheng Z, Zhang L, Yang L, et al. The critical role of gut microbiota in obesity. Front Endocrinol (Lausanne). 2022;20(13):1025706.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1493_CR21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/microorganisms10030578","volume":"10","author":"T Hrncir","year":"2022","unstructured":"Hrncir T. Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options. Microorganisms. 2022;10(3):578.","journal-title":"Microorganisms"},{"issue":"7","key":"1493_CR22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/apm.12696","volume":"125","author":"OM Hendy","year":"2017","unstructured":"Hendy OM, Elsabaawy MM, Aref MM, et al. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease. APMIS. 2017;125(7):607\u201313.","journal-title":"APMIS"},{"key":"1493_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut\u2013liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21:719\u201333. https:\/\/doi.org\/10.1038\/s41579-023-00904-3.","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"1493_CR24","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/nu15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients. 2023;15(9):2211. https:\/\/doi.org\/10.3390\/nu15092211.","journal-title":"Nutrients"},{"issue":"2","key":"1493_CR25","first-page":"195","volume":"16","author":"NE Rich","year":"2018","unstructured":"Rich NE, Oji S, Mufti AR, Browning JD, Parikh ND, Odewole M. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, diagnosis, and severity. Clin Gastroenterol Hepatol. 2018;16(2):195\u2013202.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1493_CR26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/gerona\/glx154","volume":"73","author":"GL Wehby","year":"2018","unstructured":"Wehby GL, Domingue BW, Wolinsky FD. Genetic risks for chronic conditions: implications for long-term wellbeing. J Gerontol A Biol Sci Med Sci. 2018;73(4):477\u201383.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1493_CR27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11901-023-00623-6","volume":"22","author":"C Maccali","year":"2023","unstructured":"Maccali C, Pereira IVA, et al. Risk of liver cancer in MASLD: role of genetic risk scores. Curr Hepatol Rep. 2023;22:228\u201337.","journal-title":"Curr Hepatol Rep"},{"issue":"4","key":"1493_CR28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina J, Smagris E, Stender S, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014;46(4):352\u20136.","journal-title":"Nat Genet"},{"issue":"12","key":"1493_CR29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461\u20135.","journal-title":"Nat Genet"},{"issue":"5","key":"1493_CR30","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","volume":"150","author":"RM Mancina","year":"2016","unstructured":"Mancina RM, Dongiovanni P, Petta S, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology. 2016;150(5):1219\u201330.","journal-title":"Gastroenterology"},{"issue":"1","key":"1493_CR31","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.394","volume":"6","author":"SE Ghanem","year":"2023","unstructured":"Ghanem SE, Elsabaawy MM, Abdelkareem MM, et al. Evaluation of ABCA1 gene polymorphism as a prognostic index of fibrosis progression in NAFLD patients. Endocrinol Diabetes Metab. 2023;6(1): e394.","journal-title":"Endocrinol Diabetes Metab"},{"issue":"8","key":"1493_CR32","volume":"11","author":"JS Rodr\u00edguez-Sanabria","year":"2022","unstructured":"Rodr\u00edguez-Sanabria JS, Escutia-Guti\u00e9rrez R, Rosas-Campos R, et al. An update in epigenetics in metabolic-associated fatty liver disease. Front Med (Lausanne). 2022;11(8): 770504.","journal-title":"Front Med (Lausanne)"},{"issue":"13","key":"1493_CR33","first-page":"204201882211321","volume":"28","author":"X Zhu","year":"2022","unstructured":"Zhu X, Xia M, Gao X. Update on genetics and epigenetics in metabolic associated fatty liver disease. Ther Adv Endocrinol Metab. 2022;28(13):20420188221132136.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"1493_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13237-021-00367-y","volume":"64","author":"GA Dhar","year":"2021","unstructured":"Dhar GA, Saha S, Mitra P, et al. DNA methylation and regulation of gene expression: guardian of our health. Nucleus (Calcutta). 2021;64(3):259\u201370.","journal-title":"Nucleus (Calcutta)"},{"issue":"12","key":"1493_CR35","volume":"23","author":"Q Cai","year":"2021","unstructured":"Cai Q, Gan C, Tang C, et al. Mechanism and therapeutic opportunities of histone modifications in chronic liver disease. Front Pharmacol. 2021;23(12): 784591.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1493_CR36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang X, He Y, Mackowiak B, et al. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut. 2021;70(4):784\u201395.","journal-title":"Gut"},{"issue":"11","key":"1493_CR37","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.14309\/ajg.0000000000000357","volume":"114","author":"R Harris","year":"2019","unstructured":"Harris R, Card TR, Delahooke T, Aithal GP, Guha IN. Obesity is the most common risk factor for chronic liver disease: results from a risk stratification pathway using transient elastography. Am J Gastroenterol. 2019;114(11):1744\u201352. https:\/\/doi.org\/10.14309\/ajg.0000000000000357.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"1493_CR38","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","volume":"75","author":"C Engelmann","year":"2021","unstructured":"Engelmann C, Cl\u00e0ria J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75(Suppl 1):S49-66. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.002.","journal-title":"J Hepatol."},{"issue":"3","key":"1493_CR39","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jhep.2011.09.020","volume":"56","author":"B Sun","year":"2012","unstructured":"Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol. 2012;56(3):704\u201313. https:\/\/doi.org\/10.1016\/j.jhep.2011.09.020.","journal-title":"J Hepatol"},{"issue":"1","key":"1493_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","volume":"149","author":"E Dhamija","year":"2019","unstructured":"Dhamija E, Paul SB, Kedia S. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: an increasing concern. Indian J Med Res. 2019;149(1):9\u201317. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1456_17.","journal-title":"Indian J Med Res"},{"key":"1493_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/bs.apha.2019.01.003","volume":"85","author":"J Allard","year":"2019","unstructured":"Allard J, Le Guillou D, Begriche K, Fromenty B. Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. Adv Pharmacol. 2019;85:75\u2013107. https:\/\/doi.org\/10.1016\/bs.apha.2019.01.003.","journal-title":"Adv Pharmacol"},{"issue":"18","key":"1493_CR42","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1493_CR43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jvh.12667","volume":"24","author":"MH Malespin","year":"2017","unstructured":"Malespin MH, Sievert M, Teta A, Clark CJ, Thompson N, Kalhan S, Carey W. Persistent fibrosis in patients with obesity and metabolic syndrome despite SVR after direct-acting antivirals. J Viral Hepatitis. 2017;24(6):506\u201312.","journal-title":"J Viral Hepatitis"},{"issue":"7","key":"1493_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21037\/tgh-2020-14","volume":"25","author":"Z Ahmed","year":"2022","unstructured":"Ahmed Z, Khan MA, Vazquez-Montesino LM, Ahmed A. Bariatric surgery, obesity and liver transplantation. Transl Gastroenterol Hepatol. 2022;25(7):25. https:\/\/doi.org\/10.21037\/tgh-2020-14.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"11","key":"1493_CR45","doi-asserted-by":"publisher","first-page":"204201881989752","DOI":"10.1177\/2042018819897527","volume":"22","author":"M May","year":"2020","unstructured":"May M, Schindler C, Engeli S. Modern pharmacological treatment of obese patients. Ther Adv Endocrinol Metab. 2020;22(11):2042018819897527. https:\/\/doi.org\/10.1177\/2042018819897527.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1493_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s13679-023-00497-1","volume":"12","author":"S Simati","year":"2023","unstructured":"Simati S, Kokkinos A, Dalamaga M, et al. Obesity paradox: fact or fiction? Curr Obes Rep. 2023;12:75\u201385. https:\/\/doi.org\/10.1007\/s13679-023-00497-1.","journal-title":"Curr Obes Rep"},{"issue":"3","key":"1493_CR47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.14218\/JCTH.2019.00029","volume":"7","author":"IB Curcic","year":"2019","unstructured":"Curcic IB, Berkovic MC, Kuna L, et al. Obesity paradox in chronic liver diseases: product of bias or a real thing? J Clin Transl Hepatol. 2019;7(3):275\u20139.","journal-title":"J Clin Transl Hepatol"},{"issue":"10","key":"1493_CR48","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/liv.13137","volume":"36","author":"R Karagozian","year":"2016","unstructured":"Karagozian R, Bhardwaj G, Wakefield DB, et al. Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis. Liver Int. 2016;36(10):1450\u20136.","journal-title":"Liver Int"},{"issue":"8","key":"1493_CR49","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/jgh.16590","volume":"39","author":"K Endo","year":"2024","unstructured":"Endo K, Kakisaka K, Abe T, et al. Positive impact of obesity on the prognosis of liver cirrhosis. J Gastroenterol Hepatol. 2024;39(8):1663\u201372. https:\/\/doi.org\/10.1111\/jgh.16590.","journal-title":"J Gastroenterol Hepatol"},{"key":"1493_CR50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12957-015-0713-4","volume":"13","author":"Q Li","year":"2015","unstructured":"Li Q, Xing H, Liu D, Li H. Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma. World J Surg Oncol. 2015;13:294.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1493_CR51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"4","key":"1493_CR52","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.3390\/ijms25042338","volume":"25","author":"T Vilari\u00f1o-Garc\u00eda","year":"2024","unstructured":"Vilari\u00f1o-Garc\u00eda T, Polonio-Gonz\u00e1lez ML, et al. Role of leptin in obesity, cardiovascular disease, and type 2 diabetes. Int J Mol Sci. 2024;25(4):2338. https:\/\/doi.org\/10.3390\/ijms25042338.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1493_CR53","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc14-2775","volume":"38","author":"LM Belalcazar","year":"2015","unstructured":"Belalcazar LM, Lang W, Haffner SM, et al. Improving adiponectin levels in individuals with diabetes and obesity: insights from look AHEAD. Diabetes Care. 2015;38(8):1544\u201350.","journal-title":"Diabetes Care"},{"issue":"8","key":"1493_CR54","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1210\/jc.2018-00787","volume":"103","author":"Z Wang","year":"2018","unstructured":"Wang Z, Xu M, Hu Z, Shrestha UK, Pang Q, Sun Z. Sarcopenic obesity, metabolic syndrome, and mortality in US adults: results from NHANES III. J Clin Endocrinol Metab. 2018;103(8):3148\u201356. https:\/\/doi.org\/10.1210\/jc.2018-00787.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1493_CR55","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4330\/wjc.v9.i9.731","volume":"9","author":"N Patel","year":"2017","unstructured":"Patel N, Elsaid O, Shenoy A, et al. Obesity paradox in patients undergoing coronary intervention: a review. World J Cardiol. 2017;9(9):731\u20136.","journal-title":"World J Cardiol"},{"issue":"12","key":"1493_CR56","volume":"13","author":"BA Franklin","year":"2022","unstructured":"Franklin BA, Eijsvogels TMH, Pandey A, et al. Physical activity, cardiorespiratory fitness, and cardiovascular health: a clinical practice statement of the American Society for Preventive Cardiology Part II: physical activity, cardiorespiratory fitness, minimum and goal intensities for exercise training, prescriptive methods, and special patient populations. Am J Prev Cardiol. 2022;13(12): 100425.","journal-title":"Am J Prev Cardiol"},{"issue":"2","key":"1493_CR57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1253\/circj.CJ-13-0007","volume":"77","author":"DL Swift","year":"2013","unstructured":"Swift DL, Lavie CJ, Johannsen NM, et al. Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J. 2013;77(2):281\u201392.","journal-title":"Circ J"},{"issue":"23","key":"1493_CR58","doi-asserted-by":"crossref","first-page":"12361","DOI":"10.3390\/ijerph182312361","volume":"18","author":"S Alghnam","year":"2021","unstructured":"Alghnam S, Alessy SA, Bosaad M, et al. The association between obesity and chronic conditions: results from a large electronic health records system in Saudi Arabia. Int J Environ Res Public Health. 2021;18(23):12361.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"1493_CR59","volume":"22","author":"AL Thomas","year":"2021","unstructured":"Thomas AL, Alarcon PC, Divanovic S, et al. Implications of inflammatory states on dysfunctional immune responses in aging and obesity. Front Aging. 2021;22(2): 732414.","journal-title":"Front Aging"},{"issue":"11","key":"1493_CR60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fnhum.2017.00316","volume":"20","author":"YZ Liu","year":"2017","unstructured":"Liu YZ, Wang YX, Jiang CL. Inflammation: the common pathway of stress-related diseases. Front Hum Neurosci. 2017;20(11):316.","journal-title":"Front Hum Neurosci"},{"issue":"1","key":"1493_CR61","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3945\/an.115.010207","volume":"7","author":"CJ Andersen","year":"2016","unstructured":"Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66\u201375.","journal-title":"Adv Nutr"},{"issue":"11","key":"1493_CR62","first-page":"2382","volume":"51","author":"DD Farhud","year":"2022","unstructured":"Farhud DD. Hypothetical strategies of gene and environmental influence on life expectancy: a brief review. Iran J Public Health. 2022;51(11):2382\u20137.","journal-title":"Iran J Public Health"},{"issue":"1","key":"1493_CR63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/nyas.12020","volume":"1281","author":"Q Xia","year":"2013","unstructured":"Xia Q, Grant SF. The genetics of human obesity. Ann N Y Acad Sci. 2013;1281(1):178\u201390.","journal-title":"Ann N Y Acad Sci"},{"key":"1493_CR64","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","volume":"18","author":"H Lennon","year":"2016","unstructured":"Lennon H, Sperrin M, Badrick E, et al. The obesity paradox in cancer: a review. Curr Oncol Rep. 2016;18:56.","journal-title":"Curr Oncol Rep"},{"issue":"12","key":"1493_CR65","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.amjmed.2009.06.006","volume":"122","author":"CJ Lavie","year":"2009","unstructured":"Lavie CJ, Milani RV, Artham SM, et al. The obesity paradox, weight loss, and coronary disease. Am J Med. 2009;122(12):1106\u201314.","journal-title":"Am J Med"},{"key":"1493_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/clpt.2011.87","volume":"90","author":"C Lavie","year":"2011","unstructured":"Lavie C, Milani R, Ventura H. Obesity and the \u201cobesity paradox\u201d in cardiovascular diseases. Clin Pharmacol Ther. 2011;90:23\u20135. https:\/\/doi.org\/10.1038\/clpt.2011.87.","journal-title":"Clin Pharmacol Ther"},{"issue":"14","key":"1493_CR67","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jacc.2014.01.022","volume":"63","author":"CJ Lavie","year":"2014","unstructured":"Lavie CJ, McAuley PA, Church TS, et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"1493_CR68","unstructured":"Lavie CJ. The Obesity Paradox Ebook, ISBN 9780698148512 (2014)"},{"issue":"1","key":"1493_CR69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrendo.2014.165","volume":"11","author":"CJ Lavie","year":"2015","unstructured":"Lavie CJ, De Schutter A, Milani RV. Healthy obese versus unhealthy lean: the obesity paradox. Nat Rev Endocrinol. 2015;11(1):55\u201362.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1493_CR70","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pcad.2015.12.003","volume":"58","author":"A LavieSharma","year":"2016","unstructured":"LavieSharma A, Alpert M, et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis. 2016;58(4):393\u2013400. https:\/\/doi.org\/10.1016\/j.pcad.2015.12.003.","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"1493_CR71","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026088","volume":"11","author":"CJ Lavie","year":"2022","unstructured":"Lavie CJ, daSilva-deAbreu A, Ventura HO, et al. Is there an obesity paradox in cardiogenic shock? J Am Heart Assoc. 2022;11(11): e026088.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"1493_CR72","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.cgh.2017.04.045","volume":"15","author":"AL Fracanzani","year":"2017","unstructured":"Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, Di Marco V, Camm\u00e0 C, Mensi L, Dongiovanni P, Valenti L, Crax\u00ec A, Fargion S. Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity. Clin Gastroenterol Hepatol. 2017;15(10):1604-11.e1. https:\/\/doi.org\/10.1016\/j.cgh.2017.04.045.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1493_CR73","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.mayocp.2014.06.015","volume":"89","author":"K Kalantar-Zadeh","year":"2014","unstructured":"Kalantar-Zadeh K, Rhee CM, Amin AN. To legitimize the contentious obesity paradox. Mayo Clinic Proc. 2014;89:1033\u20135.","journal-title":"Mayo Clinic Proc"},{"issue":"1","key":"1493_CR74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/EDE.0000000000000013","volume":"25","author":"MM Glymour","year":"2014","unstructured":"Glymour MM, Vittinghoff E. Commentary: selection bias as an explanation for the obesity paradox: just because it\u2019s possible doesn\u2019t mean it\u2019s plausible. Epidemiology. 2014;25(1):4\u20136.","journal-title":"Epidemiology"},{"key":"1493_CR75","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ijo.2017.99","volume":"41","author":"H Banack","year":"2017","unstructured":"Banack H, Stokes A. The \u2018obesity paradox\u2019 may not be a paradox at all. Int J Obes. 2017;41:1162\u20133.","journal-title":"Int J Obes"},{"key":"1493_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwq341","volume":"173","author":"KM Flegal","year":"2011","unstructured":"Flegal KM, Graubard BI, Williamson DF, Cooper RS. Reverse causation and illness-related weight loss in observational studies of body weight and mortality. Am J Epidemiol. 2011;173:1\u20139.","journal-title":"Am J Epidemiol"},{"key":"1493_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41366-021-00962-8","volume":"46","author":"E Hypp\u00f6nen","year":"2022","unstructured":"Hypp\u00f6nen E, Carslake D, Berry DJ, et al. Estimating the influence of body mass index (BMI) on mortality using offspring BMI as an instrumental variable. Int J Obes. 2022;46:77\u201384. https:\/\/doi.org\/10.1038\/s41366-021-00962-8.","journal-title":"Int J Obes"},{"key":"1493_CR78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/EDE.0000000000000031","volume":"25","author":"M Lajous","year":"2014","unstructured":"Lajous M, Bijon A, Fagherazzi G, et al. Body mass index, diabetes, and mortality in French women: explaining away a \u201cparadox.\u201d Epidemiology. 2014;25:10\u20134.","journal-title":"Epidemiology"},{"issue":"7","key":"1493_CR79","first-page":"802","volume":"93","author":"PA McAuley","year":"2018","unstructured":"McAuley PA, Keteyian SJ, Brawner CA, Dardari ZA, Al Rifai M, Ehrman JK, et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc. 2018;93(7):802\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1493_CR80","first-page":"163","volume":"60","author":"VW Barry","year":"2017","unstructured":"Barry VW, Baruth M, Beets MW, Durstine JL, Liu J, Blair SN. Fitness vs. fatness on all-cause mortality: a meta-analysis. Progress Cardiovasc Dis. 2017;60(2):163\u201370.","journal-title":"Progress Cardiovasc Dis"},{"key":"1493_CR81","volume-title":"Modern epidemiology","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008."},{"key":"1493_CR82","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/obr.12272","volume":"16","author":"M Bagheri","year":"2015","unstructured":"Bagheri M, Speakman JR, Shabbidar S, et al. A dose-response meta-analysais of the impact of body mass index on stroke and all-cause mortality in stroke patients: a paradox within a paradox. Obesity Rev. 2015;16:416\u201323.","journal-title":"Obesity Rev"},{"key":"1493_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2017.45","author":"S Mazimba","year":"2017","unstructured":"Mazimba S, Holland E, Nagarajan V, et al. Obesity paradox in group 1 pulmonary hypertension: analysis of the NIH-pulmonary hypertension registry. Int J Obes. 2017. https:\/\/doi.org\/10.1038\/ijo.2017.45.","journal-title":"Int J Obes"},{"issue":"6","key":"1493_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269849","volume":"17","author":"K Inagaki","year":"2022","unstructured":"Inagaki K, Tawada N, Takanashi M, et al. The association between body mass index and all-cause mortality in Japanese patients with incident hemodialysis. PLoS ONE. 2022;17(6): e0269849. https:\/\/doi.org\/10.1371\/journal.pone.0269849.","journal-title":"PLoS ONE"},{"issue":"6","key":"1493_CR85","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ajcn\/69.6.1194","volume":"69","author":"MJ Muller","year":"1999","unstructured":"Muller MJ, Bottcher J, Selberg O, Weselmann S, Schwarze M. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr. 1999;69(6):1194\u2013201.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1493_CR86","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/hep.510230516","volume":"23","author":"M Merli","year":"1996","unstructured":"Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology. 1996;23(5):1041\u20136. https:\/\/doi.org\/10.1002\/hep.510230516.","journal-title":"Hepatology"},{"issue":"8","key":"1493_CR87","first-page":"1247","volume":"14","author":"AJ Montano-Loza","year":"2016","unstructured":"Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14(8):1247\u201356.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"36","key":"1493_CR88","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","volume":"34","author":"S Moller","year":"2013","unstructured":"Moller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34(36):2804\u201311.","journal-title":"Eur Heart J"},{"issue":"11","key":"1493_CR89","doi-asserted-by":"publisher","first-page":"883","DOI":"10.4254\/wjh.v12.i11.883","volume":"12","author":"B Chapman","year":"2020","unstructured":"Chapman B, Sinclair M, Gow PJ, Testro AG. Malnutrition in cirrhosis: more food for thought. World J Hepatol. 2020;12(11):883\u201396. https:\/\/doi.org\/10.4254\/wjh.v12.i11.883.","journal-title":"World J Hepatol"},{"issue":"2","key":"1493_CR90","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5114\/aoms.2019.83063","volume":"17","author":"E Szyma\u0144ska","year":"2019","unstructured":"Szyma\u0144ska E, J\u00f3\u017awiak-Dzi\u0119cielewska DA, Gronek J, Niewczas M, Czarny W, Rokicki D, et al. Hepatic glycogen storage diseases: pathogenesis, clinical symptoms and therapeutic management. Arch Med Sci. 2019;17(2):304\u201313. https:\/\/doi.org\/10.5114\/aoms.2019.83063.","journal-title":"Arch Med Sci"},{"issue":"2020","key":"1493_CR91","doi-asserted-by":"publisher","first-page":"4020249","DOI":"10.1155\/2020\/4020249","volume":"18","author":"K Pei","year":"2020","unstructured":"Pei K, Gui T, Kan D, Feng H, Jin Y, Yang Y, Zhang Q, Du Z, Gai Z, Wu J, Li Y. An overview of lipid metabolism and nonalcoholic fatty liver disease. Biomed Res Int. 2020;18(2020):4020249. https:\/\/doi.org\/10.1155\/2020\/4020249.","journal-title":"Biomed Res Int"},{"issue":"Suppl 1","key":"1493_CR92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40261-022-01141-x","volume":"42","author":"R de la Aller Fuente","year":"2022","unstructured":"de la Aller Fuente R. Nutrition and chronic liver disease. Clin Drug Investig. 2022;42(Suppl 1):55\u201361. https:\/\/doi.org\/10.1007\/s40261-022-01141-x.","journal-title":"Clin Drug Investig"},{"issue":"12","key":"1493_CR93","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/cells12121604","volume":"12","author":"A Kasarinaite","year":"2023","unstructured":"Kasarinaite A, Sinton M, Saunders PTK, et al. The influence of sex hormones in liver function and disease. Cells. 2023;12(12):1604.","journal-title":"Cells"},{"issue":"24","key":"1493_CR94","doi-asserted-by":"crossref","first-page":"9368","DOI":"10.3390\/ijms21249368","volume":"21","author":"M Mart\u00ednez-U\u00f1a","year":"2020","unstructured":"Mart\u00ednez-U\u00f1a M, L\u00f3pez-Manche\u00f1o Y, Di\u00e9guez C, et al. Unraveling the role of leptin in liver function and its relationship with liver diseases. Int J Mol Sci. 2020;21(24):9368.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1493_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","volume":"10","author":"JA Del Campo","year":"2018","unstructured":"Del Campo JA, Gallego P, Grande L. Role of inflammatory response in liver diseases: therapeutic strategies. World J Hepatol. 2018;10(1):1\u20137.","journal-title":"World J Hepatol"},{"issue":"1","key":"1493_CR96","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/1673-5374.343891","volume":"18","author":"AAP de Boleti","year":"2023","unstructured":"de Boleti AAP, de Cardoso OPH, Frihling FBE, et al. Adipose tissue, systematic inflammation, and neurodegenerative diseases. Neural Regen Res. 2023;18(1):38\u201346.","journal-title":"Neural Regen Res"},{"issue":"11","key":"1493_CR97","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fendo.2020.00059","volume":"20","author":"E Akalestou","year":"2020","unstructured":"Akalestou E, Genser L, Rutter GA. Glucocorticoid metabolism in obesity and following weight loss. Front Endocrinol (Lausanne). 2020;20(11):59.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1493_CR98","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/17512433.2015.991716","volume":"8","author":"SA Hamed","year":"2015","unstructured":"Hamed SA. Antiepileptic drugs influences on body weight in people with epilepsy. Expert Rev Clin Pharmacol. 2015;8(1):103\u201314.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"11","key":"1493_CR99","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/oby.22969","volume":"28","author":"H Gill","year":"2020","unstructured":"Gill H, Gill B, El-Halabi S, et al. Antidepressant medications and weight change: a narrative review. Obesity (Silver Spring). 2020;28(11):2064\u201372.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"1493_CR100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","volume":"135","author":"V Ratziu","year":"2008","unstructured":"Ratziu V, Giral P, Jacqueminet S, Charlotte F, Hartemann-Heurtier A, Serfaty L, et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement by rosiglitazone therapy (FLIRT) trial. Gastroenterology. 2008;135(1):100\u201310.","journal-title":"Gastroenterology"},{"issue":"13","key":"1493_CR101","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/00002018-200124130-00004","volume":"24","author":"P Jallon","year":"2001","unstructured":"Jallon P, Picard F. Bodyweight gain and anticonvulsants: a comparative review. Drug Saf. 2001;24(13):969\u201378.","journal-title":"Drug Saf"},{"issue":"2","key":"1493_CR102","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0041-1725023","volume":"41","author":"N Haep","year":"2021","unstructured":"Haep N, Florentino RM, Squires JE, Bell A, et al. The inside-out of end-stage liver disease: hepatocytes are the keystone. Semin Liver Dis. 2021;41(2):213\u201324.","journal-title":"Semin Liver Dis"},{"issue":"3","key":"1493_CR103","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00373.2020","volume":"320","author":"SL Allen","year":"2021","unstructured":"Allen SL, Quinlan JI, Dhaliwal A, et al. Sarcopenia in chronic liver disease: mechanisms and countermeasures. Am J Physiol Gastrointest Liver Physiol. 2021;320(3):G241\u201357.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"1493_CR104","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/ijms22041917","volume":"22","author":"H Nishikawa","year":"2021","unstructured":"Nishikawa H, Enomoto H, Nishiguchi S, et al. Sarcopenic obesity in liver cirrhosis: possible mechanism and clinical impact. Int J Mol Sci. 2021;22(4):1917.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1493_CR105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/nu16030427","volume":"16","author":"E Santangeli","year":"2024","unstructured":"Santangeli E, Abbati C, Chen R, et al. Pathophysiological-based nutritional interventions in cirrhotic patients with sarcopenic obesity: a state-of-the-art narrative review. Nutrients. 2024;16(3):427.","journal-title":"Nutrients"},{"issue":"3","key":"1493_CR106","doi-asserted-by":"crossref","first-page":"417","DOI":"10.21037\/hbsn-23-175","volume":"12","author":"M Merli","year":"2023","unstructured":"Merli M, Khan S. Sarcopenic obesity: endo consensus and clinical implications in patients with chronic liver disease. Hepatobiliary Surg Nutr. 2023;12(3):417\u201320.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"4","key":"1493_CR107","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.dld.2016.11.003","volume":"49","author":"M Kalafateli","year":"2017","unstructured":"Kalafateli M, Kousoulas L, Vasileiadis I, Vasileiadis I, Thomopoulos K, Assimakopoulos SF, Triantos C. High risk of infection and sepsis in patients with cirrhosis and sarcopenia. Dig Liver Dis. 2017;49(4):446\u201351.","journal-title":"Dig Liver Dis"},{"issue":"6","key":"1493_CR108","first-page":"S328","volume":"64","author":"E Rom\u00e1n","year":"2016","unstructured":"Rom\u00e1n E, Garc\u00eda-Garc\u00eda O, Torrades MT, Rovira L, Munoz R. Sarcopenia and outcome in patients with cirrhosis undergoing liver transplantation. J Hepatol. 2016;64(6):S328\u20139.","journal-title":"J Hepatol"},{"key":"1493_CR109","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41574-024-01012-9","volume":"20","author":"E B\u00f6rgeson","year":"2024","unstructured":"B\u00f6rgeson E, Tavajoh S, Lange S, et al. The challenges of assessing adiposity in a clinical setting. Nat Rev Endocrinol. 2024;20:615\u201326. https:\/\/doi.org\/10.1038\/s41574-024-01012-9.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"1493_CR110","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/nu11071652","volume":"11","author":"J Myers","year":"2019","unstructured":"Myers J, Kokkinos P, Nyelin E. Physical activity, cardiorespiratory fitness, and the metabolic syndrome. Nutrients. 2019;11(7):1652.","journal-title":"Nutrients"},{"issue":"10","key":"1493_CR111","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1136\/bjsports-2023-107849","volume":"58","author":"JJ Lang","year":"2024","unstructured":"Lang JJ, Prince SA, Merucci K, Cadenas-Sanchez C, Chaput JP, Fraser BJ, Manyanga T, McGrath R, Ortega FB, Singh B, Tomkinson GR. Cardiorespiratory fitness is a strong and consistent predictor of morbidity and mortality among adults: an overview of meta-analyses representing over 20.9 million observations from 199 unique cohort studies. Br J Sports Med. 2024;58(10):556\u201366. https:\/\/doi.org\/10.1136\/bjsports-2023-107849.","journal-title":"Br J Sports Med"},{"key":"1493_CR112","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-04816-7_15","volume-title":"Cardiorespiratory fitness in cardiometabolic diseases","author":"MP Nguyen","year":"2019","unstructured":"Nguyen MP, Kachur S, Lavie CJ. The obesity paradox and cardiorespiratory fitness. In: Kokkinos P, Narayan P, editors. Cardiorespiratory fitness in cardiometabolic diseases. Cham: Springer; 2019. https:\/\/doi.org\/10.1007\/978-3-030-04816-7_15."},{"issue":"1","key":"1493_CR113","volume":"10","author":"AD Kaze","year":"2022","unstructured":"Kaze AD, Da Agoons D, Santhanam P, Erqou S, Ahima RS, Echouffo-Tcheugui JB. Correlates of cardiorespiratory fitness among overweight or obese individuals with type 2 diabetes. BMJ Open Diabetes Res Care. 2022;10(1): e002446.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"1493_CR114","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s42978-021-00143-z","volume":"4","author":"T Takken","year":"2022","unstructured":"Takken T, Hulzebos HJ. Is BMI Associated with cardiorespiratory fitness? A cross-sectional analysis among 8470 apparently healthy subjects aged 18\u201394 years from the low-lands fitness registry. J Sci Sport Exerc. 2022;4(3):283\u20139.","journal-title":"J Sci Sport Exerc"},{"issue":"15","key":"1493_CR115","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/eurheartj\/ehz774","volume":"41","author":"H Henriksson","year":"2020","unstructured":"Henriksson H, Henriksson P, Tynelius P, Ekstedt M, Berglind D, Labayen I, et al. Cardiorespiratory fitness, muscular strength, and obesity in adolescence and later chronic disability due to cardiovascular disease: a cohort study of 1 million men. Eur Heart J. 2020;41(15):1503\u201310.","journal-title":"Eur Heart J"},{"issue":"11","key":"1493_CR116","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s11886-023-01975-7","volume":"25","author":"A Haidar","year":"2023","unstructured":"Haidar A, Horwich T. Obesity, cardiorespiratory fitness, and cardiovascular disease. Curr Cardiol Rep. 2023;25(11):1565\u201371. https:\/\/doi.org\/10.1007\/s11886-023-01975-7.","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"1493_CR117","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jshs.2021.06.004","volume":"10","author":"Y Ezzatvar","year":"2021","unstructured":"Ezzatvar Y, Izquierdo M, N\u00fa\u00f1ez J, Calatayud J, Ram\u00edrez-V\u00e9lez R, Garc\u00eda-Hermoso A. Cardiorespiratory fitness measured with cardiopulmonary exercise testing and mortality in patients with cardiovascular disease: a systematic review and meta-analysis. J Sport Health Sci. 2021;10(6):609\u201319. https:\/\/doi.org\/10.1016\/j.jshs.2021.06.004.","journal-title":"J Sport Health Sci"},{"issue":"24","key":"1493_CR118","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1161\/CIR.0000000000000461","volume":"134","author":"R Ross","year":"2016","unstructured":"Ross R, Blair SN, Arena R, Church TS, Despr\u00e9s JP, Franklin BA, et al. A case for fitness as a clinical vital sign: a scientific statement from the American Heart Association. Circulation. 2016;134(24):e653\u201399. https:\/\/doi.org\/10.1161\/CIR.0000000000000461.","journal-title":"Circulation"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01493-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-024-01493-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01493-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T12:09:39Z","timestamp":1732968579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-024-01493-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1007\/s10238-024-01493-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The author agrees to the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"240"}}